A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy & Proton

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02012699` - Integrated Cancer Repository for Cancer Research
Completed	`NCT03096808` - Adaptive Radiotherapy for Head and Neck Cancer	Phase 2
Recruiting	`NCT05614375` - Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus
Recruiting	`NCT05114707` - Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses	Phase 2

See also

Status

Clinical Trial

Phase

Recruiting

NCT02012699 - Integrated Cancer Repository for Cancer Research

Completed

NCT03096808 - Adaptive Radiotherapy for Head and Neck Cancer

Phase 2

Recruiting

NCT05614375 - Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus

Recruiting

NCT05114707 - Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03274414
Study type	Interventional
Source	Memorial Sloan Kettering Cancer Center
Contact
Status	Completed
Phase	Phase 2
Start date	September 1, 2017
Completion date	January 13, 2023

A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms